{"summary":"1996 items in the Helious feed since 2026-11-15 (30 returned here): on this page, 30 wire headlines and 0 desk posts. Newest headline: \"Why Is POET Technologies Stock Falling Monday?\" at 16 Nov 2026 15:49 UTC. This feed is an hour behind on your plan. A free account key can ask for one call live (?fresh=1, 5 credits); GET /v1/access has the steps. Every paid plan (from $14.99 a month) gets the feed live on every call.","source":{"name":"Helious","url":"https://helious.io/news","cite_as":"Helious, https://helious.io/news","attribution":"Please credit Helious and link the url above when you use this.","live":"Request this endpoint at any time for the newest numbers your plan allows. Your plan serves the news feed 60 minutes behind; a paid Helious plan serves it live."},"data":{"items":[{"id":"cdab97359b77cb64f1765ecda6cdbce0","kind":"headline","title":"Why Is POET Technologies Stock Falling Monday?","text":"POET Technologies Inc. (NASDAQ:POET) stock fell Monday after the company reported mixed third-quarter results, with a narrower-than-expected loss but revenue below analyst estimates . The optical technology company reported a loss of 4 cents per share, beating the consensus loss estimate of 7 cents . Revenue surged 244% year over year and 80% sequentially to a record $1.03 million, missing the $1.60 million estimate. The quarter marked the company’s seventh consecutive quarter of sequential revenue growth. Earnings Snapshot Net loss narrowed to $7.6 million from $9.4 million a year earlier and $11.3 million in the previous quarter. CFO Giovanni Pacelli attributed part of the improvement to a $6.4 million noncash gain from warrant revaluation. However, excluding warrant revaluation, net loss widened to $13.9 million from approximately $7 million a year earlier. Research and development expenses totaled $5.4 million, compared with $3.7 million a year earlier. Cash and short-term investments totaled $774.3 million as of Sept. 30. Cash used in operations reached $12.7 million during the quarter. See More: Top Value Stocks Capacity Expansion And Customer Demand CEO Suresh Venkatesan said the company secured a $2.4 million purchase order from an existing customer and signed a development agreement with a major laser manufacturer. POET secured approximately tenfold greater wafer capacity at its foundry partner.","category":"news","created_at":"2026-11-16T15:49:30+00:00","carried_at":"2026-11-16T15:52:10+00:00","score":0.0,"direction":"NEUTRAL","equity_score":-2.0,"equity_direction":"BEARISH EQUITIES","topic":"equities","helious_read":"This is one small tech company's earnings miss, so it barely matters for US bonds or the wider market.","thread_id":"83753587db46e99f"},{"id":"5b081b0beafe0645b1c30aa0614fcbd6","kind":"headline","title":"Eton Pharmaceuticals at Jefferies Global Healthcare Conference: growth quickens","category":"news","created_at":"2026-11-16T15:46:34+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a small drug company's conference talk, so it does not move US markets.","thread_id":"f3162716b8a90e56"},{"id":"396e2687d55c05d2a8c1bb1aeda561dd","kind":"headline","title":"Amentum Holdings shares may move 8.6% on Nov. 23 earnings","category":"news","created_at":"2026-11-16T15:46:34+00:00","carried_at":"2026-11-16T15:46:47+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is one company's earnings report, so it does not really move US government bonds or the wider market.","thread_id":"bd38b57f75ef0280"},{"id":"7a7735ecfb4811f1744c63eeb6a160d9","kind":"headline","title":"Zoom stock may move 8.3% on Nov. 23 earnings release","category":"news","created_at":"2026-11-16T15:46:34+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is a single company's earnings preview, so it does not really move US government bonds or the wider market.","thread_id":"5429e65c05656688"},{"id":"4f64cff931002a964eaff71508a46c12","kind":"headline","title":"Nasdaq, S&P fall with Nvidia earnings, Anthropic debut looming","category":"news","created_at":"2026-11-16T15:46:34+00:00","carried_at":"2026-11-16T15:46:47+00:00","score":2.0,"direction":"BULLISH BONDS","equity_score":-4.0,"equity_direction":"BEARISH EQUITIES","topic":"equities","helious_read":"Big tech earnings worries are pulling shares down, which tends to push some money into safer government bonds.","thread_id":"012492bd5def49f5"},{"id":"a06a3ce32bcccca52a5a4bfc28fe777a","kind":"headline","title":"Palomar Holdings stock hits 52-week high at 162.38 USD","category":"news","created_at":"2026-11-16T15:46:33+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is one insurance company's share price hitting a high, so it does not move US markets.","thread_id":"19e9974836beee5e"},{"id":"22f424adac84d8c5af301db84630aaa3","kind":"headline","title":"EyePoint at Jefferies Global Healthcare Conference: pivots to dme","category":"news","created_at":"2026-11-16T15:46:33+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a small eye-care company presenting at a conference, so it does not move US markets.","thread_id":"c0e35091661ab073"},{"id":"f2e35189871dcbc20239278a3491dd9a","kind":"headline","title":"U.S. chip stocks slide as traders unwind Nvidia rival bets before earnings","category":"news","created_at":"2026-11-16T15:46:33+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":-2.0,"equity_direction":"BEARISH EQUITIES","topic":"equities","helious_read":"Chip shares slipping before Nvidia's results is a sector story, so it barely touches government bonds.","thread_id":"c71db6381d4c3bdd"},{"id":"8ebfc93a42e67c6a1c07967ff7bff078","kind":"headline","title":"Spain’s government to raise minimum wage 5.3% as election looms","category":"news","created_at":"2026-11-16T15:46:33+00:00","carried_at":"2026-11-16T15:46:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a Spanish wage rule change, so it does not really move US markets.","thread_id":"50906a1035384a6e"},{"id":"13b134a596ae845721c605fbe6468dad","kind":"headline","title":"Disney earnings preview: why subscriber count may not be most important number","category":"news","created_at":"2026-11-16T15:46:32+00:00","carried_at":"2026-11-16T15:46:45+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is a preview of one company's earnings, so it does not move US government bonds or the wider market.","thread_id":"83032f1c81c87632"},{"id":"d4a957de26cfee69638509272db3cc57","kind":"headline","title":"UK media regulator tightens curbs on online child abuse material","category":"news","created_at":"2026-11-16T15:46:26+00:00","carried_at":"2026-11-16T15:46:37+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a UK online safety rule change, so it does not really move US markets.","thread_id":"7ef8a54fcdf2eb39"},{"id":"20e2b34ca2a1b5922380fee88301294b","kind":"headline","title":"Euro: Downside risks grow against US Dollar near 1.1000 - ING","category":"news","created_at":"2026-11-16T15:45:27+00:00","carried_at":"2026-11-16T15:45:39+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is just a currency forecast about the euro, so it does not really move US bonds or shares.","thread_id":"5b3bf404be8ceeb1"},{"id":"c9ef3df397957582df7b087b5ad12b4f","kind":"headline","title":"Iambic Therapeutics, Inc. GAAP EPS of -$8.52 misses by $7.75, revenue of $11.4M beats by $3.11M","category":"news","created_at":"2026-11-16T15:41:25+00:00","carried_at":"2026-11-16T15:45:25+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is one small biotech company's earnings, so it does not really move US markets.","thread_id":"b4454b87d3eb244e"},{"id":"5f948663215fabc5eca00c2ad44e8bd1","kind":"headline","title":"Strategy stock dips as BTC sinks to below $65K; SCOTUS refuses to hear crypto bank's appeal","category":"news","created_at":"2026-11-16T15:39:00+00:00","carried_at":"2026-11-16T15:40:55+00:00","score":0.0,"direction":"NEUTRAL","equity_score":-2.0,"equity_direction":"BEARISH EQUITIES","topic":"equities","helious_read":"Crypto weakness hits one company's shares, but it barely matters for the wider US market.","thread_id":"be89723cf0471d09"},{"id":"44d500ed5b1c62480db36542d05fb392","kind":"headline","title":"Apnimed, Inc. GAAP EPS of -$1.05 misses by $0.46","category":"news","created_at":"2026-11-16T15:38:43+00:00","carried_at":"2026-11-16T15:40:55+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is one small company's earnings miss, so it does not move US government bonds or the broad market.","thread_id":"6f453706820da513"},{"id":"56621c8fc528344a5c85b54471a5b8b0","kind":"headline","title":"Corvex Secures $103M Nvidia Blackwell AI Computing Deal","text":"Corvex, Inc. (NASDAQ:MOVE) stock is trading higher during Monday’s premarket session after the company secured a three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity to a large-scale AI inference platform customer. The agreement is expected to more than double contracted annual recurring revenue at the company’s Mid-Atlantic 1 data center, from $22 million currently to approximately $56 million once the deployment is fully operational. The deployment is expected to begin generating revenue by the end of the first quarter of 2027. Corvex’s NVIDIA Blackwell Deployment The deal represents Corvex’s third NVIDIA Blackwell deployment at its Mid-Atlantic 1 facility, strengthening its position in AI computing infrastructure. The company will deliver more than 1,000 NVIDIA HGX B200 connected with NVIDIA Quantum-2 InfiniBand networking. The agreement includes take-or-pay provisions, requiring the customer to pay for reserved computing capacity regardless of actual utilization. The deployment will use 1.6 MW of IT capacity and includes GPU servers, storage, networking equipment and spare components, expected to cost approximately $78 million. Corvex secured financing covering more than 80% of the deployment cost. This includes a $26 million customer prepayment and $38 million in committed debt financing from USD.AI.","category":"news","created_at":"2026-11-16T15:36:56+00:00","carried_at":"2026-11-16T15:38:40+00:00","score":0.0,"direction":"NEUTRAL","equity_score":2.0,"equity_direction":"BULLISH EQUITIES","topic":"equities","helious_read":"This is one small company's AI computing deal, so it barely matters for US government bonds or the wider market.","thread_id":"b584ed65017806c9"},{"id":"d7621854018837a954d16e80a72bfe3b","kind":"headline","title":"U.S. average diesel prices drop below $6/gal for first time since September","category":"news","created_at":"2026-11-16T15:35:46+00:00","carried_at":"2026-11-16T15:40:55+00:00","score":2.0,"direction":"BULLISH BONDS","equity_score":2.0,"equity_direction":"BULLISH EQUITIES","topic":"chatter","helious_read":"Cheaper diesel eases transport costs a little, which is mildly good for shares and for bonds.","thread_id":"e3dfd7d508d07e4c"},{"id":"a2989dc5e2b29ea3d26f4688edddd5de","kind":"headline","title":"Trump Voices Confidence in Lutnick Despite Nvidia Fallout","text":"President Donald Trump expressed confidence in Howard Lutnick despite intense criticism being leveled at the Commerce secretary over the Nvidia Corp. scandal and shipments of advanced artificial intelligence chips to China.","category":"news","created_at":"2026-11-16T15:34:31+00:00","carried_at":"2026-11-16T15:45:26+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a political comment about a cabinet official, so it does not really move US markets.","thread_id":"4e9f76feab6eac27"},{"id":"1e1586eae9f02f5a15b9db83380bc11c","kind":"headline","title":"Helus Pharma Touts Positive Data for Depression Drug","text":"Helus Pharma Inc. (NASDAQ:HELP) reported topline results from its pivotal Phase 3 APPROACH trial, showing its novel serotonergic agonist HLP003 rapidly and durably reduced symptoms in adults with major depressive disorder . Chief Executive Officer Michael Halstead said patients with persistent depression symptoms face a major unmet need for fast-acting, well-tolerated adjunctive therapies. Halstead emphasized that these trial results demonstrate a strong therapeutic profile and build momentum as the company advances HLP003 toward regulatory approval and potential commercialization. Read Also: Definium Shares Soar After Reporting Positive Phase 3 Results For Single-Dose Depression Treatment HLP003 Achieves Rapid And Durable Depression Relief The clinical-stage pharmaceutical company evaluated deuterated psilocin candidate HLP003 alongside existing antidepressants in 222 adults with moderate-to-severe depression. HLP003 achieved statistically significant and clinically meaningful gains across primary, key secondary, and other secondary endpoints. At the six-week primary endpoint, HLP003 delivered a least squares mean reduction of 19.5 points from baseline in the MADRS total score, compared with 11.9 points for placebo. Read Also: Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints Patients experienced rapid improvement as early as Day 2, when HLP003 reduced MADRS scores by 16.1 points versus 11.0 points for placebo.","category":"news","created_at":"2026-11-16T15:34:21+00:00","carried_at":"2026-11-16T15:36:25+00:00","score":0.0,"direction":"NEUTRAL","equity_score":2.0,"equity_direction":"BULLISH EQUITIES","topic":"equities","helious_read":"This is one small drug company's trial result, so it barely touches US government bonds or the wider market.","thread_id":"33514d19e36e21e9"},{"id":"81bf5b74896988caa8299503271b8a75","kind":"headline","title":"Nuo Therapeutics GAAP EPS of -$0.01, revenue of $1.9M","text":"Nuo Therapeutics press release (AURX): Q3 GAAP EPS of -$0.01. Revenue of $1.9M (+84.5% Y/Y).","category":"news","created_at":"2026-11-16T15:34:14+00:00","carried_at":"2026-11-16T15:40:55+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"A tiny company's results have no bearing on US government bonds or the wider share market.","thread_id":"e8c0a51016414ac5"},{"id":"bace9b7908af76ff385b984c63db7bc0","kind":"headline","title":"Supreme Court declines Trump administration's DEI research grant appeal","text":"The Supreme Court on Monday declined to hear an appeal from the Trump administration in its bid to terminate tens of millions in research grants to higher education institutions in California as part of its push against diversity, equity and inclusion (DEI) push.","category":"news","created_at":"2026-11-16T15:34:01+00:00","carried_at":"2026-11-16T15:38:39+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is a court ruling on research grants, so it does not really move US markets.","thread_id":"9340fc270e47474f"},{"id":"84655f5f19b2da1356355e383a696c95","kind":"headline","title":"U.S. attorney targets another Democrat over congressional investigtions","text":"A U.S. attorney put likely incoming Senate Banking Committee Chair Sen. Elizabeth Warren (D-Mass.) on notice about her intent to investigate corporations and expected probes into the president's inner circle. Why it matters: The letter demanding Warren preserve documents related to her congressional oversight is the latest in a string of threats levied against congressional Democrats ahead of the party assuming the congressional majority — and gavels — next year. Congress' authority to investigate, hold hearings and gather testimony is a core legislative power. Analysts have long forecasted a Democratic subpoena storm into President Trump's lucrative presidency. But Democrats' plan to exercise that power and hone their focus on the administration's \"cost, chaos and corruption,\" as reported by Hans Nichols, is already facing Justice Department pushback. Driving the news: U.S. Attorney Aaron Reitz of the Southern District of Texas contended in his Sunday letter that Warren appeared \"eager to wield\" her \"gavel like a tomahawk,\" instructing her to preserve oversight records. In the strongly worded letter, he warned Warren about targeting private citizens close to the president and reiterated that any probes must serve a legislative purpose or risk violating those individuals' First Amendment rights. Those arguments echo his prior letters to Sens. Elissa Slotkin (D-Mich.) and Richard Blumenthal (D-Conn.).","category":"news","created_at":"2026-11-16T15:33:22+00:00","carried_at":"2026-11-16T15:36:25+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a political fight in Washington with no clear effect on government bonds or shares.","thread_id":"da47a575aa3bbf9c"},{"id":"f43cd84e81871c548ff635be4873fe0e","kind":"headline","title":"Biggest stock movers Monday: Crypto stocks, INTC, TU, and more","category":"news","created_at":"2026-11-16T15:32:38+00:00","carried_at":"2026-11-16T15:34:11+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is just a list of individual stock movers, so it does not really move US markets.","thread_id":"6b11251fb20b2601"},{"id":"8a482b7044fb26cce1d5fd3b45cd2bb3","kind":"headline","title":"What the west gets wrong about AI safety in China","category":"news","created_at":"2026-11-16T15:32:37+00:00","carried_at":"2026-11-16T15:32:49+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is an opinion piece about AI policy in China, so it does not move US bonds or shares.","thread_id":"43af06fe636539fe"},{"id":"0cea6798b5b544a8155594a3546800b6","kind":"headline","title":"Kremlin Says Putin-Trump Meeting in China Is Being Prepared","text":"Plans for bilateral talks between Russian President Vladimir Putin and US President Donald Trump at a summit in China are underway, the Kremlin said.","category":"news","created_at":"2026-11-16T15:32:19+00:00","carried_at":"2026-11-16T15:40:54+00:00","score":2.0,"direction":"BULLISH BONDS","equity_score":2.0,"equity_direction":"BULLISH EQUITIES","topic":"geo","helious_read":"Talks between the US and Russian leaders could ease tensions, which is mildly good for shares and government bonds.","thread_id":"5aca13fdf853aa56"},{"id":"f9568c58358d7e073fb49265d0e3146d","kind":"headline","title":"Cardiff Oncology at UBS conference: phase iii push gains speed","category":"news","created_at":"2026-11-16T15:31:34+00:00","carried_at":"2026-11-16T15:31:48+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"chatter","helious_read":"This is a small cancer drug company update, so it does not move US government bonds or the wider share market.","thread_id":"3f7c70700b784845"},{"id":"0414e1f166f7ba5c8f138100e07ab3fc","kind":"headline","title":"Atlanticus Holdings stock hits 52-week low at 19.65 USD","category":"news","created_at":"2026-11-16T15:31:34+00:00","carried_at":"2026-11-16T15:31:47+00:00","score":0.0,"direction":"NEUTRAL","equity_score":-2.0,"equity_direction":"BEARISH EQUITIES","topic":"equities","helious_read":"This is one small lender's share price falling, so it says little about US government bonds or the wider market.","thread_id":"3a8853e1aebcf69c"},{"id":"8a1818c13c01dc1f9591a1bd5908f072","kind":"headline","title":"EuroHoldings Q3 2026 slides: tanker pivot drives 179% revenue surge","category":"news","created_at":"2026-11-16T15:31:34+00:00","carried_at":"2026-11-16T15:31:48+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"equities","helious_read":"This is one small shipping company's results, so it does not really move US bonds or the broad share market.","thread_id":"c2311ec7cee3ce85"},{"id":"8ee52d65741f871169969b009fc75a56","kind":"headline","title":"Integer Holdings stock hits 52-week high at 126.96 USD","category":"news","created_at":"2026-11-16T15:31:34+00:00","carried_at":"2026-11-16T15:31:47+00:00","score":0.0,"direction":"NEUTRAL","equity_score":2.0,"equity_direction":"BULLISH EQUITIES","topic":"equities","helious_read":"This is one medical device company's share price hitting a high, so it barely matters for US markets overall.","thread_id":"b87614bac8f61e3f"},{"id":"239ef1a3fcf7972d240fd8a7a6901a00","kind":"headline","title":"Bank of Canada Governor Macklem to step down once term ends in 2027","category":"news","created_at":"2026-11-16T15:31:34+00:00","carried_at":"2026-11-16T15:31:46+00:00","score":0.0,"direction":"NEUTRAL","equity_score":0.0,"equity_direction":"NEUTRAL","topic":"cb","helious_read":"A foreign central bank chief leaving in 2027 is far off and does not move US bonds or shares today.","thread_id":"1f5d2cd0c3f9552c"}],"shown":30,"matched":1996,"tape_heartbeat":"2026-11-16T16:50:01+00:00"},"meta":{"tier":"keyless","history_days":1,"delay_sec":3600,"docs":"https://helious.io/.well-known/openapi-public.json","fresh":false,"credits_charged":1,"credits_left":49,"market_data":"none over REST (market prices start on a free account key; the delayed /v1/stream snapshot is included on every plan)","upgrade_url":"https://helious.io/pricing","upgrade_note":"You are on the 1-day sample tier with no market prices and 50 credits a month shared by your network address. A free account key (no charge) gets 7 days, 100 credits a month of its own and every price board an hour behind; with a key, fresh=1 answers a call live for 5 credits. GET /v1/access has the steps to relay to your user.","since":"2026-11-15","categories":["auction","bank","brief","corr","desk","equities","fed_speak","fx","geo","hormuz","imbalance","live_event","minutes","narrative","news","official","release","squawk","volboard"],"note":"This feed is an hour behind on your plan. A free account key can ask for one call live (?fresh=1, 5 credits); GET /v1/access has the steps. Every paid plan (from $14.99 a month) gets the feed live on every call.","as_of":"2026-11-16T16:52:47.861918+00:00"}}